Bruno Crestani Selected Research

Respiratory Insufficiency (Respiratory Failure)

1/2017	Heterogeneity of lung disease associated with NK2 homeobox 1 mutations.
3/2016	Airway-Centered Fibroelastosis: A Distinct Entity.
11/2014	Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature.
1/2014	Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia.
9/2011	Current management of lymphangioleiomyomatosis.
4/2003	Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis.
2/2002	Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno Crestani Research Topics

Disease

58	Idiopathic Pulmonary Fibrosis 01/2022 - 04/2003
34	Fibrosis (Cirrhosis) 01/2022 - 06/2005
33	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 08/2002
10	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2007
10	Lung Injury 01/2021 - 03/2002
10	Inflammation (Inflammations) 01/2020 - 01/2002
8	Asthma (Bronchial Asthma) 06/2022 - 01/2002
8	Disease Progression 01/2021 - 02/2015
8	Lung Diseases (Lung Disease) 09/2019 - 03/2002
7	Neoplasms (Cancer) 01/2022 - 03/2003
7	Pneumonia (Pneumonitis) 11/2021 - 02/2002
7	Respiratory Insufficiency (Respiratory Failure) 01/2017 - 02/2002
6	Emphysema 01/2022 - 04/2005
6	Infections 01/2022 - 01/2010
6	Microscopic Polyangiitis 01/2018 - 10/2008
5	Acute Lung Injury 07/2012 - 03/2002
4	Lung Neoplasms (Lung Cancer) 10/2021 - 01/2016
4	Sarcoidosis (Schaumann Disease) 09/2020 - 11/2016
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018 - 07/2012
4	Vasculitis (Vasculitides) 01/2018 - 03/2016
3	Cysts 06/2020 - 09/2011
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 05/2007
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2019 - 11/2014
3	Churg-Strauss Syndrome (Allergic Angiitis) 11/2017 - 03/2016
3	Chronic Obstructive Pulmonary Disease (COPD) 08/2011 - 01/2002
3	Pulmonary Emphysema 01/2008 - 04/2005
2	Weight Loss (Weight Reduction) 01/2022 - 11/2020
2	COVID-19 11/2021 - 01/2020
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2017
2	Rheumatoid Arthritis 01/2021 - 06/2011
2	Dyspnea (Shortness of Breath) 11/2020 - 02/2016
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 10/2020 - 01/2020
2	Idiopathic Interstitial Pneumonias 01/2020 - 01/2017
2	Human Influenza (Influenza) 10/2019 - 12/2016
2	Adenocarcinoma 01/2019 - 03/2003
2	Adenocarcinoma of Lung 01/2019 - 04/2016
2	Drug-Related Side Effects and Adverse Reactions 01/2019 - 01/2015
2	Hemorrhage 01/2019 - 01/2019
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 03/2016
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2017 - 01/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 11/2016
2	Hypertension (High Blood Pressure) 01/2016 - 08/2011

Drug/Important Bio-Agent (IBA)

18	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 02/2007
14	nintedanibIBA 01/2021 - 11/2014
11	pirfenidoneIBA 01/2022 - 06/2005
11	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018 - 02/2002
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2005
6	Carbon MonoxideIBA 01/2022 - 04/2003
6	CollagenIBA 01/2022 - 09/2010
6	AntibodiesIBA 01/2022 - 01/2013
6	Biological ProductsIBA 01/2022 - 12/2007
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
5	SteroidsIBA 06/2020 - 10/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2002
5	CytokinesIBA 01/2020 - 04/2002
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018 - 10/2008
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 04/2015
4	GlucocorticoidsIBA 01/2022 - 11/2014
4	Surface-Active Agents (Surfactants)IBA 10/2021 - 01/2018
4	EnzymesIBA 06/2021 - 09/2010
4	AntigensIBA 02/2021 - 10/2016
4	Hydroxyproline (4 Hydroxyproline)IBA 01/2021 - 06/2015
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 12/2012
4	telomerase RNA (bTR)IBA 01/2018 - 08/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 06/2005
4	indium-bleomycinIBA 06/2015 - 03/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2005
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2003
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021 - 01/2015
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 08/2010
3	Immunoglobulin G (IgG)IBA 12/2018 - 03/2011
3	Transcription Factors (Transcription Factor)IBA 07/2018 - 08/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 11/2007
3	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 04/2009
3	human airway trypsin-like proteaseIBA 01/2018 - 01/2017
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 06/2005
3	InterferonsIBA 12/2016 - 04/2003
3	Sirolimus (Rapamycin)FDA Link 09/2011 - 01/2007
3	Fibroblast Growth Factor 7 FDA Link 11/2007 - 04/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2019
2	A-Form DNA (A-DNA)IBA 02/2021 - 08/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2017
2	Immunoglobulin E (IgE)IBA 01/2021 - 10/2016
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2019
2	Rituximab (Mabthera)FDA Link 10/2020 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2020 - 03/2002
2	lipoarabinomannan (LAM)IBA 01/2019 - 09/2011
2	Fibronectins (Fibronectin)IBA 07/2018 - 11/2014
2	matriptaseIBA 01/2018 - 04/2016
2	AutoantibodiesIBA 01/2018 - 06/2011
2	InflammasomesIBA 12/2016 - 09/2010
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2016 - 03/2012

Therapy/Procedure

20	Therapeutics 01/2022 - 04/2003
7	Lung Transplantation 01/2022 - 04/2003
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 03/2002
2	Aftercare (After-Treatment) 01/2022 - 09/2011
2	Remission Induction 11/2017 - 01/2017
2	Pleurodesis 01/2017 - 04/2014